Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRK
07:45pm, Monday, 03'rd Mar 2025
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities laws,
Merck & Co., Inc. (MRK) Presents at TD Cowen 45th Annual Health Care Conference (Transcript)
07:13pm, Monday, 03'rd Mar 2025
Start Time: 14:30 January 1, 0000 3:05 PM ET Merck & Co., Inc.
Investors in Merck & Co., Inc. Should Contact The Gross Law Firm Before April 14, 2025 to Discuss Your Rights – MRK
01:20pm, Monday, 03'rd Mar 2025
NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Merck & Co., Inc. (NYSE: MRK).
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities laws,
MRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit
01:10pm, Monday, 03'rd Mar 2025
NEW YORK , March 3, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Merck & Co., Inc. (N
NEW YORK , March 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Merck & Co., Inc. ("Merck" or the "Company") (NYSE: MRK). Such investors are advise
April 14, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against MRK
12:25pm, Monday, 03'rd Mar 2025
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities laws,
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities laws,
MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm
09:54am, Monday, 03'rd Mar 2025
LOS ANGELES , March 3, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Merck & Co., Inc. ("Merck" or "t
These S&P 500 Stocks Have Low P/E Ratios — Time to Buy?
08:02am, Monday, 03'rd Mar 2025
Purchasing stocks at the right time can maximize your return on investment, especially if you plan to buy and hold shares toward a short-term or medium-term financial goal. A stock's P/E ratio can giv
Buy These Mispriced Dividend Icons For Retirement Income
08:00am, Monday, 03'rd Mar 2025
Realty Income and Merck offer compelling value with strong fundamentals, attractive valuations, and reliable, growing income streams, making them opportunistic buys for long-term investors. Realty Inc
Shareholders that lost money on Merck & Co., Inc.(MRK) should contact Levi & Korsinsky about pending Class Action - MRK
07:25am, Monday, 03'rd Mar 2025
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities laws,
NEW YORK CITY, NY / ACCESS Newswire / March 3, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Merck
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Merck Lawsuit - MRK
05:45am, Monday, 03'rd Mar 2025
NEW YORK , March 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Merck & Co., Inc. (NYSE: MRK). Shareholders who purchased shares of MRK during the class peri
My Top 10 High-Yield Dividend Stocks For March 2025
01:04am, Monday, 03'rd Mar 2025
SPY stumbles in February, erasing some of its year-to-date gains. VYM is running strong and extends its lead over SPY in 2025. The top 10 stocks on the watchlist for March 2025 offer a 3.56% dividend
